Impaired BMPR2 signalling creates an imbalance in TGFβ/BMP signalling favouring TGFβ and may underlie vascular remodelling in PAH patients with and withoutBMPR2 mutations. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.